A Dose-Finding Study of Folotyn® (Pralatrexate Injection) Plus CHOP With Peripheral T-Cell Lymphoma (PTCL)

NCT02594267 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral T-Cell Lymphoma (PTCL)

Interventions

DRUG: Pralatrexate Injection

Sponsor

Acrotech Biopharma Inc.

Collaborators

[object Object]